Hindustan Agrigenetics Ltd (519574)

At its 36th Annual General Meeting on September 29, 2026, Hindustan Agrigenetics Limited secured shareholder approval for the appointment and regularisation of key leadership. Mr. Rajendra Naniwadekar, who holds 11,05,928 shares, was confirmed as Managing Director alongside regularisation as a Director. Additionally, three Independent Directors were regularised: Mr. Kodanda Ram Babu Punukollu and Mr. Shashank Vaidya for 3-year tenures, and Mrs. Vidya Sobhanaditya Jonnalagadda (holding 21,637 shares) for a 5-year tenure ending October 2030.

• Shareholders approved regularisation and appointment of Rajendra Naniwadekar as Managing Director on September 29, 2026
• Managing Director Rajendra Naniwadekar holds 11,05,928 shares in the company
• Independent Director Vidya Sobhanaditya Jonnalagadda appointed for 5 years through October 17, 2030, holding 21,637 shares
• Two Independent Directors, Kodanda Ram Babu Punukollu and Shashank Vaidya, regularised for 3-year tenures through September 29, 2028

Hindustan Agrigenetics Limited announced the outcome of its Board meeting held on August 29, 2026. The Board approved convening the 36th Annual General Meeting (AGM) on September 29, 2026, at 11:30 AM via video conference. The register of members and share transfer books will remain closed from September 23, 2026, to September 29, 2026. The Board also appointed CDSL for e-voting services and M/s. G.R. Gupta & Associates as scrutinizer for the AGM.

• 36th Annual General Meeting convened for September 29, 2026, at 11:30 AM via video conference
• Book closure fixed from September 23, 2026, to September 29, 2026
• Board approved the Annual Report, Director's Report, and Secretarial Audit Report
• CDSL appointed as e-voting intermediary and M/s. G.R. Gupta & Associates appointed as scrutinizers

Hindustan Agrigenetics Ltd has scheduled a meeting of its Board of Directors on Saturday, August 29, 2026. The board will consider and finalize the date, time, and venue for convening the 36th Annual General Meeting (AGM) for the financial year ended March 31, 2026. It will also approve the AGM notice, Board's Report, book closure dates, and appoint an e-voting agency and scrutinizer. This is a routine administrative compliance filing under Regulation 29 of SEBI LODR.

• Board meeting scheduled for Saturday, August 29, 2026
• Board to fix the day, date, time, and venue for the 36th Annual General Meeting (AGM)
• Approval of Notice of AGM, Board's Report, and Secretarial Audit Report for FY ended March 31, 2026
• Fixing of dates for book closure and appointment of remote e-voting agency and scrutinizer

Hindustan Agrigenetics reported a standalone net profit of Rs 30.06 Lakhs for the quarter ended June 30, 2026, down 25.2% YoY from Rs 40.19 Lakhs in Q1 FY26, but turning around from a net loss of Rs 41.22 Lakhs in Q4 FY26. Core revenue from operations was Rs 0.00 Lakhs during the quarter, compared to Rs 4.33 Lakhs in Q1 FY26. Total income was entirely driven by other income of Rs 43.50 Lakhs, comprising Rs 20.64 Lakhs in interest income and Rs 22.86 Lakhs in investment valuation gains. Total expenses for the quarter stood at Rs 10.97 Lakhs, and basic EPS stood at Rs 0.68.

• Net profit stood at Rs 30.06 Lakhs for Q1 ended June 30, 2026, versus Rs 40.19 Lakhs in Q1 FY26 and a net loss of Rs 41.22 Lakhs in Q4 FY26
• Revenue from operations was nil (Rs 0.00 Lakhs) compared to Rs 4.33 Lakhs in the year-ago period
• Total revenue of Rs 43.50 Lakhs consisted entirely of other income (Rs 20.64 Lakhs interest income and Rs 22.86 Lakhs investment gains)
• Total expenses declined to Rs 10.97 Lakhs from Rs 15.29 Lakhs in Q1 FY26 and Rs 84.35 Lakhs in Q4 FY26
• Basic and diluted EPS for the quarter was Rs 0.68

Hindustan Agrigenetics reported a standalone net profit of ₹30.06 lakh for the quarter ended June 30, 2026, recovering from a net loss of ₹41.22 lakh in Q4 FY26 and down from ₹40.19 lakh in Q1 FY26. Operational revenue remained at zero for the quarter, compared to ₹4.33 lakh in the prior-year period. Total revenue of ₹43.50 lakh was driven entirely by other income, consisting of ₹20.64 lakh in interest income and ₹22.86 lakh in mark-to-market investment gains. Total expenses declined sharply to ₹10.97 lakh compared to ₹84.35 lakh in Q4 FY26.

• Revenue from operations was ₹0.00 (Nil) for Q1 FY27 compared to ₹4.33 lakh in Q1 FY26
• Net profit stood at ₹30.06 lakh versus a net loss of ₹41.22 lakh in Q4 FY26 and profit of ₹40.19 lakh in Q1 FY26
• Total other income stood at ₹43.50 lakh, including ₹20.64 lakh interest and ₹22.86 lakh investment valuation changes
• Total expenses dropped to ₹10.97 lakh from ₹84.35 lakh in Q4 FY26 and ₹15.29 lakh in Q1 FY26
• Basic and diluted EPS reported at ₹0.68 per share (face value ₹10.00)

Hindustan Agrigenetics Ltd has scheduled a board meeting for August 14, 2026, to approve unaudited financial results for the quarter ended June 30, 2026. This comes at a critical time as the company has reported zero revenue for the last three consecutive quarters (Sep 2025 to Mar 2026). With a net worth of Rs 12 Cr and a TTM revenue of Rs 0 Cr, the upcoming results will indicate if there is any operational revival. The stock has seen a significant decline of 45.4% over the last 12 months.

• Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results.
• Company reported zero revenue in the previous three quarters (Sep 2025, Dec 2025, and Mar 2026).
• Promoter holding is relatively low at 25.35% as of June 2026.
• Trading window is closed until 48 hours after the results are filed with the exchange.